Edmond de Rothschild (Suisse)’s iShares Biotechnology ETF IBB Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$87K	Buy	+900	New	+$85.6K	0.03%	268

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s IBB Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) opened a new position in iShares Biotechnology ETF (IBB) in Q3 2016: 900 shares worth $87K. The stake represents 0.03% of the portfolio and ranks #268 among its holdings.

463 funds tracked by Wall St. Rank hold IBB as of Q3 2016.

Edmond de Rothschild (Suisse) held 900 shares of iShares Biotechnology ETF worth $87K as of Q3 2016.
iShares Biotechnology ETF was a new Edmond de Rothschild (Suisse) position in Q3 2016.
iShares Biotechnology ETF made up 0.03% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #268 holding.
463 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.